Prosecution Insights
Last updated: April 19, 2026
Application No. 17/950,451

SIMULATED TISSUE STRUCTURE COMPOSITION AND USE FOR SURGICAL TRAINING

Non-Final OA §102§103
Filed
Sep 22, 2022
Examiner
HULL, JAMES B
Art Unit
3715
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Applied Medical Resources Corporation
OA Round
1 (Non-Final)
45%
Grant Probability
Moderate
1-2
OA Rounds
3y 5m
To Grant
97%
With Interview

Examiner Intelligence

Grants 45% of resolved cases
45%
Career Allow Rate
270 granted / 602 resolved
-25.1% vs TC avg
Strong +52% interview lift
Without
With
+52.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
33 currently pending
Career history
635
Total Applications
across all art units

Statute-Specific Performance

§101
23.2%
-16.8% vs TC avg
§103
31.5%
-8.5% vs TC avg
§102
15.0%
-25.0% vs TC avg
§112
27.3%
-12.7% vs TC avg
Black line = Tech Center average estimate • Based on career data from 602 resolved cases

Office Action

§102 §103
DETAILED ACTION Remarks The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 9-16 and 23 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected inventions II and III, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on 10/6/25. Although Applicant states that claim 9, which is directed to a method of making, is amended to require the structure of claim 1, the reasons for restriction mailed on 8/8/25 still apply to the pending claims and thus are maintained. In particular, the product of invention I (e.g., claim 1) can be made by another and materially different process than invention II (e.g., claim 9), such as 3D printing, which is another and materially different process than the molding process of claim 9. Therefore, Applicant’s argument is not found persuasive. The requirement is still deemed proper and is therefore made FINAL. Accordingly, claims 9-16 and 23 are withdrawn, and claims 1, 4-8, and 24-30 are under examination. Claim Objections Claim 5 is objected to because of the following informalities: Claim 5 depends on cancelled claim 2. Appropriate correction is required. For the purposes of examination, claim 5 is interpreted as dependent on independent claim 1. Claim Rejections – 35 USC 102 (AIA ) The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by US 2018/0005549 A1 to BLACK. Regarding claim 1, BLACK teaches a simulated tissue structure (par. 0115: model 200… provides the one or more dissecting layer 226) comprising: a first inner layer comprising a continuous length of fibers (par. 0115: fibers); a second inner layer comprising an interlaced planar threaded material (par. 0115: mesh); and an outer layer (par. 0115: silicone) surrounding the first inner layer and the second inner layer, the outer layer comprising of a material different from the first and second inner layers (par. 0115: fibers embedded in silicone; embedded mesh), wherein the first inner layer and the second inner layer are configured to provide a longitudinal strength to the simulated tissue structure (par. 0115: fibers embedded in silicone that make the incisions and separation of the simulated uterus 216 realistic …embedded mesh that makes it possible for the silicone to hold sutures without easily tearing). Claim Rejections - 35 USC § 103 (AIA ) The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102 of this title, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries set forth in Graham v. John Deere Co., 383 U.S. 1, 148 USPQ 459 (1966), that are applied for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim 4 is rejected under 35 U.S.C. 103 as being obvious over BLACK, as applied to claim 1, in view of US 2014/0248596 A1 to HART. Regarding claim 4, BLACK teaches the elements above including an outer layer comprising silicone (par. 0115), but does not expressly disclose the silicone is a non- conductive silicone. However, HART discloses a related surgical simulation system comprising at least one simulated body organ (Abstract), and further discloses using materials including non-conductive silicone, as it is suitable for forming artificial organs (par. 0062). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the use of non-conductive silicone, as taught by HART, to the silicone outer layer of BLACK, in order to apply a known material that is recognized as suitable for forming artificial organs, thereby achieving predictable results. Claim 8 is rejected under 35 U.S.C. 103 as being obvious over BLACK, as applied to claim 1, in view of US 2018/0240366 A1 to FELSINGER. Regarding claim 8, BLACK teaches the elements above including an outer layer comprising silicone (par. 0115), but does not expressly disclose the silicone is a conductive material. However, FELSINGER discloses using conductive silicone to produce synthetic organs (par. 0032). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to incorporate the use of conductive silicone, as taught by FELSINGER, to the silicone outer layer of BLACK, in order to apply a known material that is recognized as suitable for forming synthetic organs, thereby achieving predictable results. Allowable Subject Matter Claims 5-7 and 24-30 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to James Hull whose telephone number is 571-272-0996. The examiner can normally be reached on Monday-Friday from 8:00am to 5:00pm MST. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Xuan Thai, can be reached at telephone number 571-272-7147. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) Form at https://www.uspto.gov/patents/uspto-automated- interview-request-air-form. /JAMES B HULL/Primary Examiner, Art Unit 3715
Read full office action

Prosecution Timeline

Sep 22, 2022
Application Filed
Jan 12, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12603017
SYSTEMS AND METHODS FOR IMMERSIVE WEATHER AND LATERAL DYNAMICS SIMULATION
2y 5m to grant Granted Apr 14, 2026
Patent 12594475
SKI JUMP AND WINGSUIT FREE FLIGHT SIMULATOR
2y 5m to grant Granted Apr 07, 2026
Patent 12597364
Weld Training Simulations using Desktop Devices, Modular Workpieces, and Simulated Welding Equipment
2y 5m to grant Granted Apr 07, 2026
Patent 12597368
ROOFING MODEL KIT THAT IS A SCALABLE REPLICA OF A COMMERCIAL ROOFING SYSTEM
2y 5m to grant Granted Apr 07, 2026
Patent 12586486
PROJECTED BLOODSTAIN GENERATOR AND METHOD OF GENERATING PROJECTED BLOODSTAIN USING THE SAME
2y 5m to grant Granted Mar 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
45%
Grant Probability
97%
With Interview (+52.3%)
3y 5m
Median Time to Grant
Low
PTA Risk
Based on 602 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month